Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Telomir Pharmaceuticals / Equity Bottom-Up

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases.</li><li> The company announced preclinical test results that showed Telomir-1 reversed multiple symptoms in an animal model of Wilson's disease.</li><li>These results provide further proof of the potential of Telomir-1 to reduce aging-related diseases.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced preclinical test results that showed Telomir-1 reversed multiple symptoms in an animal model of Wilson's disease.These results provide further proof of the potential of Telomir-1 to reduce aging-related diseases.

TELO: Data Shows Potential Treatment for Age-Related Diseases

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age.</li><li> The company announced preclinical test results that showed Telomir-1 restored vision and retinal structure in Age-Related Macular Degeneration in an animal model-an encouraging result for millions of AMD sufferers.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company announced preclinical test results that showed Telomir-1 restored vision and retinal structure in Age-Related Macular Degeneration in an animal model-an encouraging result for millions of AMD sufferers.

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age.</li><li> The company announced the identification of Telomir-Ag2 as a novel drug candidate for the treatment of bacterial infections.</li><li>This discovery has the potential to be a new weapon in fighting drug-resistant pathogens.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company announced the identification of Telomir-Ag2 as a novel drug candidate for the treatment of bacterial infections.This discovery has the potential to be a new weapon in fighting drug-resistant pathogens.

<ul><li>Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age.</li><li> The company released test results that showed Telomir-1 reverses multiple signs of cellular decline across human cell lines.</li><li>This provides a foundation for the company to pursue treatments of autism and spasmodic dysphonia.</li></ul>

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend human lifespans and improve quality of life as people age. The company released test results that showed Telomir-1 reverses multiple signs of cellular decline across human cell lines.This provides a foundation for the company to pursue treatments of autism and spasmodic dysphonia.

TELO: Tests Show Positive Cell Damage Repair Ability

United States

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Telomir Pharmaceuticals (TELO US)

TELO: Exciting News for AMD Sufferers

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: New Discovery Offers Great Promise

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: New Discovery Offers Great Promise

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: Tests Show Positive Cell Damage Repair Ability

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

TELO: Data Shows Potential Treatment for Age-Related Diseases

Telomir Pharmaceuticals is a preclinical stage company focused on reversing biological aging and degenerative diseases. The company announced...

Zacks Small Cap Research

TELO: Exciting News for AMD Sufferers

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: New Discovery Offers Great Promise

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: New Discovery Offers Great Promise

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research

TELO: Tests Show Positive Cell Damage Repair Ability

Telomir Pharmaceuticals is a preclinical stage company focused on the science of lengthening telomere caps, which the company believes will extend...

Zacks Small Cap Research